Thank you, Ark, and good morning, everyone. In the fourth quarter, EPAM generated revenues of $1.25 billion, a year-over-year increase of 7.9% on a reported basis, including revenues from recent acquisitions, NEORIS and First Derivative. On an organic constant currency basis, revenues grew 1% compared to the fourth quarter of 2023. In Q4, we are pleased to return to year-over-year organic revenue growth. Organic revenues exceeded our Q4 guidance due to higher than expected new project starts, indicating modestly improving client sentiment. Due to the quarter's significant inorganic revenue contribution, I will speak to both organic and inorganic revenues as I discuss industry vertical and geographic performance. Beginning with industry verticals, I want to echo Ark's comments that, in Q4, five out of six of our industry verticals delivered sequential organic revenue growth. Only the travel and consumer vertical declined Q3 to Q4. Financial services delivered very strong growth of 15.9% year-over-year, reflecting 4.3% organic and 11.6% inorganic growth, driven by continued strength in the banking, insurance and payment sector. Life sciences and healthcare increased 8.6% on a year-over-year basis, reflecting 5.7% organic and 2.9% inorganic growth. Growth in the quarter was driven primarily by clients in life sciences, including some revenues derived from new logo accounts. Software and high-tech increased 7.7% year-over-year, reflecting 6.4% organic and 1.3% inorganic growth. Consumer goods, retail and travel decreased 3% year-over-year, reflecting a negative 5.7% organic and a positive 2.7% inorganic growth, largely due to declines in consumer products and retail, partially offset by growth in travel. Business information and media declined 3.9% year-over-year, reflecting negative 4.7% organic and positive 0.8% inorganic growth. Revenue in the quarter was impacted by the previously discussed ramp down of the top 20 clients. However, sequentially, we were encouraged to see the vertical return to strong growth as we continue to build momentum. And finally, our emerging verticals delivered very strong growth of 24.8%, reflecting 3% organic and 21.8% inorganic growth. Growth was primarily driven by clients in energy, manufacturing and industrial materials with significant contribution coming from NEORIS. From a geographic perspective, the Americas, our largest region, representing 60% of our Q4 revenues, increased 11.4% year-over-year, reflecting 2.7% organic and 8.7% inorganic growth. EMEA, representing 38% of our Q4 revenues, increased 3.1% year-over-year, reflecting negative 1.4% organic and positive 4.5% inorganic growth. In the quarter, the region continued to show sequential organic revenue improvement. And finally, APAC increased 4.3% year-over-year and represents 2% of our revenues. In Q4, revenues from our top 20 clients grew 4% year-over-year, while revenues from clients outside our top 20 increased 10%. Moving down the income statement, our GAAP gross margin for the quarter was 30.4% compared to 31.1% in Q4 of last year. Non-GAAP gross margin for the quarter was 32.2% compared to 33% for the same quarter last year. Relative to Q4 2023, gross margin in Q4 2024 was negatively impacted by compensation increases, including those resulting from our 2024 promotion campaign, which we were not able to offset through pricing, as well as lower profitability of recent acquisitions. The compensation increases along with lower profitability from acquisitions and negative foreign exchange impact exceeded the benefits of improved utilization and the positive impact from the Polish R&D incentive. GAAP SG&A was 17.4% of revenue compared to 18.5% in Q4 of last year. Non-GAAP SG&A came in at 14.4% of revenue compared to 14.2% in the same period last year. SG&A measured as a percent of revenue is now higher in part due to our recent acquisitions running with higher SG&A levels compared to our standalone business. SG&A expense for Q4 of 2024 reflects SG&A associated with recent acquisitions as well as higher variable compensation compared to Q4 2023. GAAP income from operations was $137 million or 10.9% of revenue in the quarter compared to $122 million or 10.6% of revenue in Q4 of last year. Non-GAAP income from operations was $208 million or 16.7% of revenue in the quarter compared to $200 million or 17.3% of revenue in Q4 of last year. Our GAAP effective tax rate for the quarter came in at 24.8% and our non-GAAP effective tax rate was 24%. Diluted earnings per share on a GAAP basis was $1.80. Our non-GAAP diluted EPS was $2.84, reflecting an increase of $0.09 or 3.3% compared to the same quarter in 2023. In Q4, there were approximately 57.4 million diluted shares outstanding. Turning to our cash flow and balance sheet. Cash flow from operations for Q4 was $130 million compared to $171 million in the same quarter of 2023. Free cash flow was $115 million compared to free cash flow of $161 million in the same quarter last year. We ended the quarter with approximately $1.3 billion in cash and cash equivalents, which is lower compared to the same quarter last year due to our recently completed acquisitions. At the end of Q4, DSO was 70 days compared to 74 days in Q3 2024 and 71 days in the same quarter last year. Share repurchases in the fourth quarter were approximately 53,000 shares for $13 million at an average price of $241.99 per share. Moving on to a few operational metrics for the quarter. We ended Q4 with more than 55,100 consultants, designers, engineers, trainers and architects, a growth of 16.3% compared to Q4 of 2023. This was a result of recent acquisitions, which contributed nearly 6,000 delivery professionals, in addition to solid organic growth, which contributed sequential net additions of around 1,500 employees in the quarter. Our total headcount for the quarter was 61,200 employees. Utilization was 76.2% compared to 74.4% in Q4 of last year and 76.4% in Q3 2024. Turning to our 2024 full year results. Revenues for the year were $473 billion, up 0.8% on a reported basis year-over-year. On an organic constant currency basis, revenues were down 1.7% year-over-year. GAAP income from operations was $545 million, an increase of 8.6% year-over-year and represented 11.5% of revenue. GAAP income from operations benefited from the recognition of $69 million of incentives related to research and development activities performed in Poland and was negatively impacted by $31 million of severance-related costs. Our non-GAAP income from operations was $779 million, a growth of 1.8% compared to the prior year and represented 16.5% of revenue. Our non-GAAP income from operations benefited from the recognition of $45 million of incentives related to research and development activities performed in Poland in 2024. Our GAAP effective tax rate for the year was 22.2%. Our non-GAAP effective tax rate was 24%. Diluted earnings per share on a GAAP basis was $7.84. Non-GAAP EPS, which excludes adjustments for stock-based compensation, acquisition-related costs and certain other one-time items, including costs associated with our cost optimization programs, was $10.86, reflecting a 2.5% increase over fiscal 2023. In 2024, there were approximately 58 million weighted average diluted shares outstanding. Cash flow from operations was $559 million compared to $563 million for 2023 and free cash flow was $527 million, reflecting an 83.7% adjusted net income conversion. And finally, shares repurchased in 2024 were approximately 1,854,000 shares for $398 million at an average price of $214.65 per share. Now let's turn to guidance. Before moving to the specifics of our 2025 and Q1 outlook, I would like to provide some thoughts to help frame our guidance. We have been pleased with the progress we are making on demand generation and we'll continue to prioritize revenue growth into 2025. We see stability in client budgets and some degree of shift in spending towards growth and strategic programs. In 2025, we expect flat year-over-year organic revenue growth in Q1, followed by continued improvement throughout the year. In terms of profitability for 2025, we do expect to run the business at somewhat lower levels of profitability than we have in past years. As Ark mentioned, we are investing in retaining our top talent as well as further accelerating investments in our advanced GenAI platforms and tools. Compensation increases to retain talent for future growth, combined with the limited ability to improve client pricing in the near-term and additional pressure from dilutive impact of recent acquisitions will continue to put pressure on profitability this year. However, we do expect to see improvement in our profitability levels from the first half to the second half of the year. Our guidance assumes that we will continue to be able to deliver from our Ukraine delivery centers at productivity levels similar to those achieved in 2024. Now starting with our full year outlook, revenue growth will be in the range of 10% to 14% with an inorganic contribution of approximately 10% for 2025. Foreign exchange is expected to have a negative impact of 0.9%. We expect GAAP income from operations to be in the range of 9% to 10% and non-GAAP income from operations to be in the range of 14.5% to 15.5%. We expect our GAAP effective tax rate to be approximately 24%, our non-GAAP effective tax rate, which excludes excess tax benefits related to stock-based compensation will also be 24%. For earnings per share, we expect the GAAP diluted EPS will be in the range of $6.78 to $7.08 for the full year and non-GAAP diluted EPS will be in the range of $10.45 to $10.75 for the full year. We expect weighted average share count of 58.1 million fully diluted shares outstanding. For Q1 of 2025, we expect revenues to be in the range of $1.275 billion to $1.290 billion, producing year-over-year growth of approximately 10%. Our guidance reflects an inorganic contribution of 11.4% with a 1.4% negative FX impact during the quarter. For the first quarter, we expect GAAP income from operations to be in the range of 6.5% to 7.5% and non-GAAP income from operations to be in the range of 12.5% to 13.5%. Our Q1 income from operations guide reflects the impact of resetting social security caps, the negative impact of 2024 compensation increases, which we were unable to offset with better pricing, dilution from recent acquisitions, and a slightly softer revenue in the month of January as clients in certain verticals finalize budgets. For the first quarter, we expect GAAP income from operations to be in the range of 6.5% to 7.5% and non-GAAP income from operations to be in the range of 12.5% to 13.5%. Our Q1 income from operations guide reflects the impact of resetting social security caps, the negative impact of 2024 compensation increases, which we were unable to offset with better pricing, dilution from recent acquisitions and slightly softer revenues in the month of January as clients in certain verticals finalize budgets. We expect a weighted average share count of 57.7 million diluted shares outstanding. Finally, a few key assumptions that support our GAAP to non-GAAP measurements for 2025. Stock-based compensation expense is expected to be approximately $194 million with $50 million in Q1, $44 million in Q2 and $50 million in each remaining quarter. Amortization of intangibles is expected to be approximately $68 million for the year with approximately $18 million in Q1 and $17 million in each remaining quarter. The impact of foreign exchange is expected to be approximately $1 million loss each quarter. Tax effect of non-GAAP adjustments is expected to be approximately $61 million for the year, was $17 million in Q1, $14 million in Q2, and $15 million in each remaining quarter. We expect excess tax benefits to be around $14 million for the full year with approximately $7 million in Q1, $2 million in Q2, $1 million in Q3 and $3 million in Q4. Severance, driven by our 2024 cost optimization program is expected to be $6 million in Q1 and $1 million in Q2. Finally, one more assumption outside of our GAAP to non-GAAP items. We maintain a significant level of cash and are generating a healthy level of interest income. However, based on the reduction in cash resulting from the recent acquisitions, we are expecting interest and other income to be smaller in 2025 compared to 2024, with around $18 million for the 2025 full year, with $4 million in Q1 and Q2 and $5 million in each remaining quarter. My thanks to all the EPAMers who made 2024 a successful year and will help us drive growth throughout 2025. Operator, let's open the call for questions.